Pengfei Xu

1PUBLICATIONS
3CO-AUTHORS
Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 20, 2026
Discovery of YYSW001: A Highly Selective, Orally Bioavailable JAK1 Inhibitor Achieving Efficacy under a Moderate-Inhibition Strategy with Improved Preclinical Tolerability.

Kaiyong Hu, Yezhi Wang, Pengfei Xu

Pageof 1

Frequent Collaborators

1 joint publications

Zhiyu Li

1 joint publications

Zhixia Qiu

1 joint publications

Jinlei Bian